Chitinase‐3‐like protein 1 (CHI3L1/YKL‐40), a glial activation marker expressed in both microglia and astrocytes, along with TREM2, a microglia‐specific biomarker, shows potential for both AD diagnosis and therapeutic monitoring. Here, TREM2 is linked to Alzheimer disease.